XML 45 R35.htm IDEA: XBRL DOCUMENT v3.10.0.1
Organization and Summary of Significant Accounting Policies - Impact of Newly Adopted Standard Related to Revenue Recognition (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Dec. 31, 2017
New Accounting Pronouncements or Change in Accounting Principle [Line Items]          
Revenues $ 188,673 $ 181,042 $ 371,292 $ 329,595  
Gross profit 88,783 78,132 171,238 140,323  
Selling, general, and administrative 65,937 61,922 131,222 123,862  
Provision for (benefit from) income taxes (150) (2,385) (4,966) (11,058)  
Net income (loss) $ 6,588 $ 1,880 $ 9,308 $ (8,455)  
Net income per share $ 0.17 $ 0.05 $ 0.24 $ (0.23)  
Accounts receivable and unbilled receivables, net $ 174,570   $ 174,570   $ 190,046
Prepaid expenses 18,266   18,266   20,392
Prepaid commissions 38,620   38,620   41,432
Other long-term assets 59,655   59,655   49,316
Deferred revenues, net 85,776   85,776   78,774
Long-term deferred revenues 8,957   8,957   10,623
Long-term deferred tax liabilities 34,788   34,788   41,446
Stockholders’ equity $ 588,640   $ 588,640   554,341
Automation and analytics          
New Accounting Pronouncements or Change in Accounting Principle [Line Items]          
Revenues   $ 148,584   $ 270,754  
Gross profit   67,868   121,277  
Medication adherence          
New Accounting Pronouncements or Change in Accounting Principle [Line Items]          
Revenues   32,458   58,841  
Gross profit   10,264   19,046  
As reported          
New Accounting Pronouncements or Change in Accounting Principle [Line Items]          
Selling, general, and administrative   63,468   128,093  
Provision for (benefit from) income taxes   (3,045)   (11,983)  
Net income (loss)   $ 837   $ (9,917)  
Net income per share   $ 0.02   $ (0.27)  
Accounts receivable and unbilled receivables, net         189,227
Prepaid expenses         36,060
Prepaid commissions         0
Other long-term assets         39,841
Deferred revenues, net         86,104
Long-term deferred revenues         17,244
Long-term deferred tax liabilities         28,579
Stockholders’ equity         517,199
As reported | Automation and analytics          
New Accounting Pronouncements or Change in Accounting Principle [Line Items]          
Revenues   $ 148,427   $ 272,598  
Gross profit   67,711   123,121  
As reported | Medication adherence          
New Accounting Pronouncements or Change in Accounting Principle [Line Items]          
Revenues   32,458   58,841  
Gross profit   10,264   19,046  
Adjustment | Accounting Standards Update 2014-09          
New Accounting Pronouncements or Change in Accounting Principle [Line Items]          
Selling, general, and administrative   (1,546)   (4,231)  
Provision for (benefit from) income taxes   660   925  
Net income (loss)   $ 1,043   $ 1,462  
Net income per share   $ 0.03   $ 0.04  
Accounts receivable and unbilled receivables, net         819
Prepaid expenses         (15,668)
Prepaid commissions         41,432
Other long-term assets         9,475
Deferred revenues, net         (7,330)
Long-term deferred revenues         (6,621)
Long-term deferred tax liabilities         12,867
Stockholders’ equity         $ 37,142
Adjustment | Accounting Standards Update 2014-09 | Automation and analytics          
New Accounting Pronouncements or Change in Accounting Principle [Line Items]          
Revenues   $ 157   $ (1,844)  
Gross profit   157   (1,844)  
Adjustment | Accounting Standards Update 2014-09 | Medication adherence          
New Accounting Pronouncements or Change in Accounting Principle [Line Items]          
Revenues   0   0  
Gross profit   $ 0   $ 0